EXTON, PA, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The FDA's approval of Eli Lilly’s Omvoh for Crohn’s disease marks a significant milestone as the therapy becomes the second IL-23 inhibitor ...

Omvoh (mirikizumab-mrkz) has potential interactions with certain vaccines and health conditions. These interactions could cause harmful effects in some people. Omvoh is used in adults to treat ...

The senior vice president at Lilly Immunology Development discusses recent developments with Omvoh. The European Medicines Agency’s Committee for Medicinal Products for Human Use recently issued a ...

Just weeks after unveiling big merger plans, OrthoIndy announced Thursday that Dr. Matthew Lavery has been promoted to president at the Indianapolis-based orthopedic practice. Effective Monday ...

Eli Lilly and Co.’s approval for Omvoh to treat moderate to severe Crohn’s disease in adults marks the Indianapolis company’s growing presence in the treatment of inflammatory bowel disease.

Modeling simulations predict that transitioning to once every 4 weeks of lecanemab after 18 months will maintain clinical and biomarker therapy benefits. The Food and Drug Administration (FDA) has ...

Share on Pinterest Wrist-worn devices could give advance notice of when the wearer might experience an IBD flare. Image credit: Studio Marmellata/Stocksy. For people with the unpredictable ...

The PFS outlines robust economic potential for the Gilmour project. It presents an after-tax net present value of A$231-million at a flat gold price of A$3 500/oz, which increases to A$354-million ...

Omvoh has possible interactions with certain vaccines. Examples include the chickenpox vaccine and the nasal spray flu vaccine (FluMist). Talk with your doctor to avoid potentially harmful effects ...

The OPFS estimates a net present value of $2.3-billion, compared with the $2.4-billion estimated in the initial PFS. The project is expected to deliver earnings before interest, taxes ...

Sanofi’s (NASDAQ:SNY) consumer healthcare unit Opella announced Tuesday that the U.S. FDA has lifted a clinical hold on a trial designed to test an over-the-counter version of its erectile ...